Endoscopic surgery of the cervical spine is gaining increasing traction among minimally invasive spinal surgeons. Technology advances with improved miniaturized optical- and surgical access systems have purported expansion of endoscopic minimally invasive spinal surgery techniques into the cervical spine. However, many spine surgeons still hesitate to treat common painful conditions of the cervical spine with endoscopic procedures. The high risk of neurologic- and vascular injury is of concern to many of them. Additionally, damage to the trachea, esophagus, or the recurrent laryngeal nerve may put the patient at significant risk for the deleterious postoperative course. Nevertheless, increased acceptance of endoscopy by traditionally trained spine surgeons in other areas of the spine coupled with more widely available training events and unanswered patient demand has reenergized spine surgeons’ interest in the endoscopic platform for the cervical spine. This book is valuable knowledge for Postgraduate residents and fellows in orthopedic surgery, neurosurgery, general surgery, and health professionals in pain management clinics.
Medicine & Health
Herbal Medicine: Back to the Future compiles expert reviews on the application of herbal medicines (including Ayurveda, Chinese traditional medicines and alternative therapies) to treat different ailments. The book series demonstrates the use of sophisticated methods to understand traditional medicine, while providing readers a glimpse into the future of herbal medicine.
New Columbia studies quantify the effect of the COVID pandemic on health care workers' sleep patterns and the potential damaging consequences of sleep disturbance on their mental health.
- Journal of Affective Disorders
- American Heart Association, NIH/National Institutes of Health, Robert Wood Johnson Foundation
Therapeutic agents have an impressive history in drug discovery and development which led to the identification of numerous phenomenal lead drug candidates. The current therapeutic regimens are allied with several inverse biological effects. Therefore, there is an urgent need for innovative and technological strategies to help in medical diagnosis and management. With the advancement of new technologies in medicinal chemistry, several highly specific, biocompatible, and non-toxic therapeutic agents are discovered and successfully applied for diverse clinical applications. Nanotechnology has perceived historic progress in the last few decades and recently proved its efficacy in every field of science and technology. Nanotechnology-based pharmaceuticals offered multifaceted and alternative methodologies to an overwhelmed conventional limitation of clinical therapies. Expertise in designing and developing Nano formulation helped in targeted drug delivery. Recently, the use of innovative therapeutic agents, particularly in Nano medicine, has accounted for a significant portion of the global pharmaceutical market and is predicted to continue to grow rapidly in the near future.
Researchers at Trinity College Dublin have made a major discovery in understanding motor neuron disease (MND). The research team has found that MND has 4 distinct patterns of changes in electrical signals that can be identified using EEG (electroencephalography).
- Science Foundation Ireland, Health Research Board (Ireland), Irish Research Council, American ALS Association, British MND Association, Research Motor Neurone (Charity)
By understanding the epidemiology and population biology of a significant and high-priority pathogen, Enteroccocus faecium (E. faecium) in Irish hospitals, researchers from Trinity College and colleagues are, for the first time, providing the evidence base for more effective surveillance, and infection and prevention control strategies aimed at minimising the spread of the antibiotic resistant bacteria.
- Journal of Antimicrobial Chemotherapy
Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study conducted at Tampere University in Finland finds. In statin users, screening did not increase the incidence of prostate cancer as it did in other men.
- JAMA Oncology